Torthaí cuardaigh - Chin‐Yang Li

Beachtaigh na torthaí
  1. 1
    Systemic mast cell disease: A clinical and hematopathologic study of 26 cases

    Systemic mast cell disease: A clinical and hematopathologic study of 26 cases de réir Thomas A. Webb, Chin‐Yang Li, Lung T. Yam

    Foilsithe / Cruthaithe 1982
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes

    Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes de réir Ronald S. Go, Chin‐Yang Li, Ayalew Tefferi, Robert L. Phyliky

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Treatment of Systemic Mast-Cell Disease with Cladribine

    Treatment of Systemic Mast-Cell Disease with Cladribine de réir Ayalew Tefferi, Chin‐Yang Li, Joseph H. Butterfield, H. Clark Hoagland

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Epstein-Barr virus infection in Richter's transformation

    Epstein-Barr virus infection in Richter's transformation de réir Stephen M. Ansell, Chin‐Yang Li, Ricardo V. Lloyd, Robert L. Phyliky

    Foilsithe / Cruthaithe 1999
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate or 2‐chlorodeoxyadenosine

    Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate or 2... de réir Ken Hong Lim, Animesh Pardanani, Joseph H. Butterfield, Chin‐Yang Li, Ayalew Tefferi

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Systemic Mast Cell Disease

    Systemic Mast Cell Disease de réir William D. Travis, Chin‐Yang Li, Erik J. Bergstralh, Lung T. Yam, Ronald G. Swee

    Foilsithe / Cruthaithe 1988
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study

    Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study de réir David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Leigh A. Gray, Ayalew Tefferi

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Significance of systemic mast cell disease with associated hematologic disorders

    Significance of systemic mast cell disease with associated hematologic disorders de réir William D. Travis, Chin‐Yang Li, Lung T. Yam, Erik J. Bergstralh, Ronald G. Swee

    Foilsithe / Cruthaithe 1988
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

    Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases de réir Ruben A. Mesa, Chin‐Yang Li, Rhett P. Ketterling, Georgene Schroeder, Ryan A. Knudson, Ayalew Tefferi

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia

    Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia de réir Ayalew Tefferi, Ruben A. Mesa, Georgene Schroeder, Curtis A. Hanson, Chin‐Yang Li, Gordon W. Dewald

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Validation and comparison of contemporary prognostic models in primary myelofibrosis

    Validation and comparison of contemporary prognostic models in primary myelofibrosis de réir Ayalew Tefferi, Jocelin Huang, Susan M. Schwager, Chin‐Yang Li, Wenting Wu, Animesh Pardanani, Ruben A. Mesa

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Risk factors for leukemic transformation in patients with primary myelofibrosis

    Risk factors for leukemic transformation in patients with primary myelofibrosis de réir Jocelin Huang, Chin‐Yang Li, Ruben A. Mesa, Wentling Wu, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults

    WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults de réir Animesh Pardanani, Ken-Hong Lim, Terra L. Lasho, Christy Finke, Rebecca F. McClure, Chin‐Yang Li, Ayalew Tefferi

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Thalidomide treatment in myelofibrosis with myeloid metaplasia

    Thalidomide treatment in myelofibrosis with myeloid metaplasia de réir Michelle A. Elliott, Ruben A. Mesa, Chin‐Yang Li, C. Christopher Hook, Stephen M. Ansell, Ralph Levitt, Susan M. Geyer, Ayalew Tefferi

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    The <i>JAK2</i><sup>V617F</sup> tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

    The <i>JAK2</i><sup>V617F</sup> tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates de réir Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Martha Wadleigh, D. Gary Gilliland

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903

    Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903 de réir Ruben A. Mesa, Xiaopan Yao, Larry D. Cripe, Chin Yang Li, Mark R. Litzow, Elisabeth Paietta, Jacob M. Rowe, Ayalew Tefferi, Martin S. Tallman

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

    Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors de réir Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy Finke, Mrinal M. Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin‐Yang Li, Animesh Pardanani

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Clinical correlates of <i>JAK2</i>V617F allele burden in essential thrombocythemia

    Clinical correlates of <i>JAK2</i>V617F allele burden in essential thrombocythemia de réir Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Christy Finke, Naseema Gangat, Alexandra P. Wolanskyj, Chin‐Yang Li, Wenting Wu, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Concomitant neutrophil <i>JAK2</i><sup>V617F</sup> mutation screening and <i>PRV‐1</i> expression analysis in myeloproliferative disorders and secondary polycythaemia

    Concomitant neutrophil <i>JAK2</i><sup>V617F</sup> mutation screening and <i>PRV‐1</i> expression analysis in myeloproliferative disorders and secondary polycythaemia de réir Ayalew Tefferi, Shireen Sirhan, Terra L. Lasho, Susan M. Schwager, Chin‐Yang Li, David Dingli, Alexandra P. Wolanskyj, David P. Steensma, Ruben A. Mesa, D. Gary Gilliland

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

    FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia de réir Animesh Pardanani, Stephanie R. Brockman, Sarah F. Paternoster, Heather C. Flynn, Rhett P. Ketterling, Terra L. Lasho, Ching-Liang Ho, Chin‐Yang Li, Gordon W. Dewald, Ayalew Tefferi

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: